Founded in 2014, Severna's mission has been to service hospitals, clinics & healthcare systems across the US with strategic pharmaceutical and medical device supply chain solutions to overcome disruption and ongoing specialty needs. Through rigorous Quality Systems, Severna Health works to identify, inspect, and match high quality products with Severna clients. Whether a Severna Health product, or a Severna Health vetted regulatory compliant supplier, Severna will work to problem solve supply chain disruption with long term solutions.
Severna Health is a SAM certified small business registered and established with the Federal Food and Drug Administration as a Specification Developer and Repackager. Severna Health has multiple ongoing FDA 510k fillings and manufacturer direct partnerships to provide additional ongoing solutions to critically disrupted Pharmaceuticals, Medical Devices and Supplies.
Severna Health was formed in 2014 to address continual supply chain disruption felt by hospitals and large healthcare systems nationwide. With a diversified focus on Pharmaceuticals, Laboratory & ivd services, and now Personnel Protective Equipment (PPE), Severna Health is uniquely positioned to provide reliable solutions during uncertain times.
Nitrile Latex Gloves
Our nitrile gloves are made from 100% synthetic nitrile latex. They are comfortable with excellent fit making them useful in a wide range of applications. Our gloves provide better protection and are more durable than many standard gloves. These gloves are powder-free, and non-sterile. They are not medical grade gloves. One size fits most people and the gloves can be worn on either hand. When properly worn, they are thick 6 mil nitrile making them puncture and abrasion resistant. They should be disposed of after use.Order
Proven strategies with the ability and relationships to make them happen.
Healthcare providers need more than single source providers.Through a comprehensive Quality Assurance Quality Control (QAQC) review process, Severna Health throughly inspects 503b vendors to help hospitals, clinics and healthcare facilities navigate an ever changing landscape of 503b Outsourcing.
Severna Health operates on the frontlines with hospital pharmacy directors and buyers to resolve supply chain disruption through careful product selection criteria and vendor identification.
Current areas of concentration are DEA Class I, II & III Controls, IV bags, Syringe suites, and specialty vial compounds serving OR & ER, Oncology, Urology, Ophthalmic & wellness Departments.
Filling unmet demand for critical medicines.
A primary focus on 503b compound & wholesale distribution
Healthcare systems need more than single-source 503b suppliers. Severna evaluates 503b vendors to the latest FDA guidance to ensure Standard Operating Procedures and quality standards are met. Since the very inception of FDA 503b, Severna’s mission has been to assist our healthcare clients in making confident well-educated buying decisions while providing a single point of contact for all Severna-approved 503b suppliers.
Years of Experience
Our experience makes the difference.
As an FDA-registered and established specification developer and repackager, Severna Health is constantly exploring partnership opportunities for FDA product filings (NDA, ANDA & 510k) and facility development. Severna has internal FDA consultants, and 3rd party strategic partners capable of handling facility development and/or Quality Systems implementation/maintenance, as well as FDA product-specific filings. With existing distribution channels, Severna Health can assist with product sales and marketing, further enhancing any partnership opportunities.
Focused on addressing drug, testing, and equipment shortages, Severna Health works to improve supply chain deficiencies. Our pharmaceutical candidates are based on existing, well-known active pharmaceutical ingredients (APIs). With established mechanisms of action, safety profiles, and therapeutic activity, we avoid the risks of clinical development and regulatory approval. Our PPE and testing products are American-made. Severna health has multiple FDA 510K filings for nitrile gloves and are actively pursuing additional filings for critically disrupted medical devices.
For more information on Severna Health services and opportunities please contact us.
As a founding member, Scott’s responsibilities focus on business strategy & business plan execution. Scott currently serves as the Chief Executive Officer of Severna Health and Severna Laboratories, an FDA registered repackager & specification developer servicing FDA regulated pharmaceutical & medical device manufacturing, 503B Compounding & Wholesale Distribution. Since founding Severna in 2014, the Company has experienced significant expansion and year-over-year growth.
Before founding Severna, Scott served as Executive Vice President of an FDA regulated 503B Outsourcing Facility, Bryce Laboratories, Inc. Scott’s primary focus was to accelerate growth through a concentration of quality assurance, compliance, product control, & industry diversification.
Scott began his career with American Express Financial Advisors, before becoming Area Manager of Operations for AppleOne, Inc., and later Vice President of Business Development & Account Management for BrainBox Enterprises, Inc., where he oversaw marketing & strategic growth plans for clients such as Magellan Health, Discovery Health, Shire Pharmaceuticals, etc.
Scott has a Bachelor's degree from Hobart College. He and his wife Shannon reside in Annapolis, MD with their two children.
As a founding member, Matt’s responsibilities will focus on sales plan development & execution. Matt currently serves as Chief Revenue Officer of Severna Health, where he is responsible for the day to day sales & performance for Severna. In its sixth year of operations, Matt has Severna pacing to capacity in 2020.
Prior to Severna, Matt was the Executive Vice President of Sales for Pharmagen, Inc., a publicly held Pharmaceutical company focused on the nation’s sterile injectable shortage through independent wholesale distribution & pharmaceutical compounding/ADMIX.
Matt was instrumental in growing two pharmaceutical wholesalers, Global Pharmaceutical Sourcing (GPS) and Premium Rx National (PRN). At GPS, Matt developed the sales infrastructure, training program, and compensation plans while recruiting, hiring, and training 34 representatives generating $81 million in gross revenue within the first five years of operations. Matt’s success at PRN resulted in generated revenues from zero to $14 million within the first twelve months of operation.
Matt is a graduate of the University of Maryland, College Park, with a Bachelor of Arts in Communications. He and his wife reside in Annapolis, MD with their two children.